[1]
Gedeborg, R. et al. 2023. Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden. Scandinavian Journal of Urology. 58, (Nov. 2023), 93–100. DOI:https://doi.org/10.2340/sju.v58.9572.